Home/Filings/4/0001493152-22-035926
4//SEC Filing

Litchev Boyan Vesselinov 4

Accession 0001493152-22-035926

CIK 0001857044other

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 9:06 PM ET

Size

9.0 KB

Accession

0001493152-22-035926

Insider Transaction Report

Form 4
Period: 2022-01-31
Litchev Boyan Vesselinov
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2022-11-22$1.83/sh+500$915650 total
  • Purchase

    Common Stock

    2022-01-31$4.65/sh+100$465100 total
  • Purchase

    Common Stock

    2022-03-02$4.09/sh+50$205150 total
  • Purchase

    Common Stock

    2022-12-01$1.87/sh+500$9351,150 total

Documents

1 file

Issuer

Indaptus Therapeutics, Inc.

CIK 0001857044

Entity typeother

Related Parties

1
  • filerCIK 0001902726

Filing Metadata

Form type
4
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 9:06 PM ET
Size
9.0 KB